1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial.

J. Costa,A. Abizaid,R. Costa,F. Feres,L. Tanajura,A. Abizaid,G. Maldonado,R. Staico,Dimytri A Siqueira,A. Sousa,R. Bonan,J. Sousa
DOI: https://doi.org/10.1016/j.jcin.2009.02.009
2009-05-01
Abstract:
What problem does this paper attempt to address?